Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors

被引:119
作者
Leonetti, F
Favia, A
Rao, A
Aliano, R
Paluszcak, A
Hartmann, RW
Carotti, A
机构
[1] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
[2] Univ Messina, Dipartimento Farmacochim, I-98168 Messina, Italy
[3] Univ Saarland, Pharmaceut & Med Chem Dept, D-66041 Saarbrucken, Germany
关键词
D O I
10.1021/jm049535j
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, and biological evaluation of a series of new aromatase inhibitors bearing an imidazole or triazole ring linked to a fluorene (A), indenodiazine (B), or coumarin scaffold (C) are reported. Properly substituted coumarin derivatives displayed the highest aromatase inhibitory potency and selectivity over 17-alpha-hydroxylase/17-20 lyase. The modeling of the aromatase inhibition data by Comparative Molecular Field Analysis (CoMFA/GOLPE 3D QSAR approach) led to the development of a PLS model with good fitting and predictive powers (n = 22, ONC = 3, r(2) = 0.949, s = 0.216, and q(2) = 0.715). The relationship between aromatase inhibition and the steric and electrostatic fields generated by the examined azole inhibitors enables a clear understanding of the nature and spatial location of the main interactions modulating the aromatase inhibitory potency.
引用
收藏
页码:6792 / 6803
页数:12
相关论文
共 56 条
[1]   Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid [J].
Ahmed, S ;
James, K ;
Owen, CP .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) :2391-2394
[2]   Inhibition of monoamine oxidase-B by condensed pyridazines and pyrimidines: Effects of lipophilicity and structure-activity relationships [J].
Altomare, C ;
Cellamare, S ;
Summo, L ;
Catto, M ;
Carotti, A ;
Thull, U ;
Carrupt, PA ;
Testa, B ;
Stoeckli-Evans, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) :3812-3820
[3]   Aromatase inhibitors: Current indications and future prospects for treatment of postmenopausal breast cancer [J].
Arora, A ;
Potter, JF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) :611-616
[4]  
Banting L, 1989, Prog Med Chem, V26, P253, DOI 10.1016/S0079-6468(08)70242-X
[5]  
Brueggemeier Robert W, 2002, Expert Rev Anticancer Ther, V2, P181, DOI 10.1586/14737140.2.2.181
[6]   Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents [J].
Brueggemeier, RW ;
Richards, JA ;
Joomprabutra, S ;
Bhat, AS ;
Whetstone, JL .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) :75-84
[7]   Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase [J].
Brühlmann, C ;
Ooms, F ;
Carrupt, PA ;
Testa, B ;
Catto, M ;
Leonetti, F ;
Altomare, C ;
Carotti, A .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (19) :3195-3198
[8]  
Buzdar Aman U, 2003, Clin Breast Cancer, V4 Suppl 2, pS84, DOI 10.3816/CBC.2003.s.020
[9]   Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. Synthesis and SAR studies [J].
Carotti, A ;
Carrieri, A ;
Chimichi, S ;
Boccalini, M ;
Cosimelli, B ;
Gnerre, C ;
Carotti, A ;
Carrupt, PA ;
Testa, B .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (24) :3551-3555
[10]   Linking CoMFA and protein homology models of enzyme-inhibitor interactions: an application to non-steroidal aromatase inhibitors [J].
Cavalli, A ;
Greco, G ;
Novellino, E ;
Recanatini, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (12) :2771-2780